powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1306105309
Michael Cheng
MD
Hematology-Oncology
San Francisco,
CA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
PRESCRIBING · PART D · 2024
Total Rx claims
128
Beneficiaries
—
Total drug cost
$2.0M
Distinct drugs
5
Brand share
82.0%
Top prescribed drugs
Osimertinib Mesylate
70 claims
Alectinib Hcl
24 claims
Prochlorperazine Maleate
12 claims
Ondansetron Hcl
11 claims
Tepotinib Hcl
11 claims
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (1)
CCN 050454
Hospital
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
244
Unique beneficiaries
—
Total services
735
Distinct HCPCS
4
Medicare payment
$50K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 957 Hematology-Oncology providers in CA — below median (cohort median 4,173).
QUALITY · MIPS · 2024
Final MIPS score
84.9
Quality
81.1
Cost
71.5
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.42%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$2K
Payment records
15
By payment type
Travel and Lodging
$1K
Food and Beverage
$546
Top paying entities
Travel and Lodging
$1K
Food and Beverage
$546
